Aalberts N.V.
Aalberts N.V. (0NX1.IL) Financial Performance & Income Statement Overview
Review Aalberts N.V. (0NX1.IL) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Aalberts N.V. (0NX1.IL) Income Statement & Financial Overview
View the income breakdown for Aalberts N.V. 0NX1.IL across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.53B | $1.62B | $1.61B | $1.72B |
| Cost of Revenue | $1.15B | $586.20M | $1.15B | $1.21B |
| Gross Profit | $380.60M | $1.03B | $452.10M | $505.90M |
| Gross Profit Ratio | $0.25 | $0.64 | $0.28 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $294.10M | $472.20M | $264.90M | $279.00M |
| Operating Expenses | $267.60M | $818.90M | $224.20M | $270.40M |
| Total Costs & Expenses | -$1.42B | $1.41B | $1.38B | $1.48B |
| Interest Income | $0.00 | $0.00 | $0.00 | $20.20M |
| Interest Expense | $17.00M | $13.80M | $19.20M | $20.20M |
| Depreciation & Amortization | $115.00M | $103.50M | $101.30M | $97.90M |
| EBITDA | $193.60M | $317.30M | $329.20M | $333.40M |
| EBITDA Ratio | $0.13 | $0.20 | $0.20 | $0.19 |
| Operating Income | $113.00M | $213.80M | $227.90M | $235.50M |
| Operating Income Ratio | $0.07 | $0.13 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | -$51.40M | -$13.80M | -$19.20M | -$20.20M |
| Income Before Tax | $61.60M | $200.00M | $208.70M | $215.30M |
| Income Before Tax Ratio | $0.04 | $0.12 | $0.13 | $0.13 |
| Income Tax Expense | $24.30M | $49.90M | $50.70M | $52.80M |
| Net Income | $29.90M | $149.20M | $155.80M | $160.00M |
| Net Income Ratio | $0.02 | $0.09 | $0.10 | $0.09 |
| EPS | $0.27 | $1.35 | $1.41 | $1.45 |
| Diluted EPS | $0.27 | $1.35 | $1.41 | $1.44 |
| Weighted Avg Shares Outstanding | $110.58M | $110.52M | $110.58M | $110.58M |
| Weighted Avg Shares Outstanding (Diluted) | $110.58M | $110.52M | $110.58M | $111.11M |
Over the past four quarters, Aalberts N.V. demonstrated steady revenue growth, increasing from $1.72B in Q2 2023 to $1.53B in Q4 2024. Operating income reached $113.00M in Q4 2024, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $193.60M, reflecting operational efficiency. Net income dropped to $29.90M, with EPS at $0.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan